Waters Announces Additions to Leadership Team
Waters Corporation has announced the addition of Richard Chang and Xiao Ran Yu to its Asia Pacific leadership team. Chang has been appointed as Vice President of Waters’ Asia Pacific Operations and Yu has been appointed as General Manager of Waters China.
Waters Corporation (Milford, Massachusetts, USA) has announced the addition of Richard Chang and Xiao Ran Yu to its Asia Pacific leadership team. Chang has been appointed as Vice President of Waters’ Asia Pacific Operations and Yu has been appointed as General Manager of Waters China.
“Mr. Chang’s and Mr. Yu’s impressive proven track records have demonstrated an intimate understanding of the marketplaces in the region,” said Dr. Mike Harrington, Senior Vice President, Global Markets, Waters Corporation. “With their extensive experience and strong commitment, our China business has become the single biggest market for Waters outside the US. We strongly believe that they will continue to drive growth in the Asia Pacific region,” he continued.
Beginning his career with Waters in Taiwan, Chang moved to China following four successful years as General Manager to help develop the Chinese market. Appointed as President of Greater China operations in 2012, he has led Waters’ significant growth within the Asia Pacific region.
“It’s my great honour to lead the Asia Pacific team and I look forward to working closely with our customers and partners in meeting their needs, and bringing Waters innovation to them in the most accessible way,” said Chang.
“I’m excited to join the leadership team in Asia Pacific and apply my wealth of experience and passion for science and technology to support customers in China,” enthused Yu, who has more than 22 years of experience in the analytical science industry. The former operations manager for South China had led his team to significant sales revenues during his tenure.
Waters are hopeful these two new appointments can drive growth within the region and capitalize on the emerging strength of the Asia Pacific markets.
For more information please visit www.waters.com.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
